Get started
Ascendis Pharma A/S
Long

ASND ( NASDAQ BIOTECH) rises on earnings and FDA submission

31
ASND

as can be seen on the hourly chart ASND is in an uptrend
recent earnings were a good beat,
RSI is quite high and it is at one than one STD above
the multi-session VWAP.

ASND is on watch for a pullback to find an entry
as it has high upside.
AwesomeAvani
ASNDbiotechTechnical IndicatorsPHARMPHARMApullbackpullbacktradeTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
ASNDbiotechTechnical IndicatorsPHARMPHARMApullbackpullbacktradeTrend Analysis
AwesomeAvani

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.